kabutan

NIPPON KAYAKU Firm on Acquisition of Pharmaceutical Manufacturing Business from Fuji Pharma

Tue Mar 31, 2026 10:17 am JST Catalyst

NIPPON KAYAKU <4272> traded firmly. After the close of trading on the 30th, the company announced it will acquire shares of a company that will succeed part of the pharmaceutical manufacturing business of Fuji Pharma (Omiya-ku, Saitama City). The company will take over the operations of the Toyama No. 2 Plant, which primarily engages in contract development and manufacturing of pharmaceutical products (injections). This acquisition aims to strengthen the stable supply system and expand production capacity for anticancer drugs and biosimilars.

Source: MINKABU PRESS

Related Articles